Smith, Bryan D.
Kaufman, Michael D.
Lu, Wei-Ping
Gupta, Anu
Leary, Cynthia B.
Wise, Scott C.
Rutkoski, Thomas J.
Ahn, Yu Mi
Al-Ani, Gada
Bulfer, Stacie L.
Caldwell, Timothy M.
Chun, Lawrence
Ensinger, Carol L.
Hood, Molly M.
McKinley, Arin
Patt, William C.
Ruiz-Soto, Rodrigo
Su, Ying
Telikepalli, Hanumaiah
Town, Ajia
Turner, Benjamin A.
Vogeti, Lakshminarayana
Vogeti, Subha
Yates, Karen
Janku, Filip
Abdul Razak, Albiruni Ryan
Rosen, Oliver
Heinrich, Michael C.
Flynn, Daniel L.
Funding for this research was provided by:
Deciphera Pharmaceuticals
This article is maintained by: Elsevier
Article Title: Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants
Journal Title: Cancer Cell
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ccell.2019.04.006
Content Type: article
Copyright: © 2019 Elsevier Inc.